SEM vs. EHC, IMVT, ALPN, DOCS, MDGL, TMDX, NUVL, KRYS, RDNT, and INSP
Should you be buying Select Medical stock or one of its competitors? The main competitors of Select Medical include Encompass Health (EHC), Immunovant (IMVT), Alpine Immune Sciences (ALPN), Doximity (DOCS), Madrigal Pharmaceuticals (MDGL), TransMedics Group (TMDX), Nuvalent (NUVL), Krystal Biotech (KRYS), RadNet (RDNT), and Inspire Medical Systems (INSP). These companies are all part of the "medical" sector.
Encompass Health (NYSE:EHC) and Select Medical (NYSE:SEM) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings.
In the previous week, Encompass Health and Encompass Health both had 9 articles in the media. Select Medical's average media sentiment score of 0.99 beat Encompass Health's score of 0.57 indicating that Encompass Health is being referred to more favorably in the media.
Encompass Health has a net margin of 7.60% compared to Encompass Health's net margin of 3.97%. Encompass Health's return on equity of 18.11% beat Select Medical's return on equity.
Encompass Health has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Select Medical has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500.
Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.
Encompass Health has higher earnings, but lower revenue than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.
97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 89.5% of Select Medical shares are owned by institutional investors. 2.1% of Encompass Health shares are owned by company insiders. Comparatively, 19.1% of Select Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Select Medical pays out 23.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Encompass Health currently has a consensus price target of $90.29, suggesting a potential upside of 5.66%. Select Medical has a consensus price target of $34.25, suggesting a potential upside of 0.88%. Given Select Medical's stronger consensus rating and higher possible upside, analysts plainly believe Encompass Health is more favorable than Select Medical.
Summary
Encompass Health beats Select Medical on 15 of the 20 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding SEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Select Medical Competitors List
Related Companies and Tools
